Investors and stakeholders can access the live audio broadcast through the company’s investor relations portal at ir.evolent.com. Analysts planning to participate in the interactive question-and-answer session are required to dial 855.940.9467, or 412.317.6034 for international callers, at least 15 minutes before the start of the call. For those unable to attend the live session, an audio replay will remain available on the investor relations website for 90 days following the event.
Evolent Health Sets November 5 Date for Third Quarter Earnings
Evolent Health will disclose its financial results for the third quarter of 2026 on Thursday, November 5, before the opening bell. The announcement precedes a live conference call scheduled for 8:30 a.m. ET, where company leadership will address performance metrics and the firm’s strategy for managing complex health conditions.
Comments (0)
No comments yet. Be the first!